GA101-miniCHOP Regimen for the Treatment of Elderly Unfit Patients With Diffuse Large B-cell Non-Hodgkin's Lymphoma A Phase II Study of the Fondazione Italiana Linfomi (FIL)
Phase of Trial: Phase II
Latest Information Update: 04 Dec 2017
At a glance
- Drugs Obinutuzumab (Primary)
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- Acronyms FIL_GAEL
- 29 Nov 2017 Status changed from recruiting to suspended.
- 24 Aug 2016 Status changed from active, no longer recruiting to recruiting.
- 07 May 2015 New trial record